Table 2.

Dysregulated ingenuity canonical pathways.

Ingenuity canonical pathways	− log(p-value)
Epithelial adherens junction signaling	2.93
Sperm motility	2.73
Role of tissue factor in cancer	2.56
ID1 signaling pathway	2.47
ERK5 signaling	2.21
Inhibition of angiogenesis by TSP1	1.9
Tight junction signaling	1.9
Glutamate degradation II	1.83
N-acetylglucosamine degradation I	1.83
Aspartate biosynthesis	1.83
Docosahexaenoic acid (DHA) signaling	1.81
Pyrimidine ribonucleotides interconversion	1.81
Natural killer cell signaling	1.76
Synaptic long-term depression	1.76
Pyrimidine ribonucleotides de novo biosynthesis	1.75
Ephrin receptor signaling	1.73
3-Phosphoinositide biosynthesis	1.71
l-Cysteine degradation I	1.7
N-acetylglucosamine degradation II	1.7
ERK/MAPK signaling	1.64
Ephrin A signaling	1.64

Top ingenuity pathway analysis-enriched canonical pathways.